geo
The FDA has long been criticized for its “revolving door” with Big Pharma where top executives move back and forth in top positions. The case of FDA approval of BioNTech’s Comirnaty gene therapy injection abandoned all traditional precedents in pushing it through: incomplete data and trials and no review board.
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…